| Trial ID: | L4534 |
| Source ID: | NCT00806936
|
| Associated Drug: |
Human Insulin
|
| Title: |
Observational Study to Investigate the Efficacy and Safety of Human Insulin or Insulin Analogue Treatments in Type 2 Diabetes Subjects
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: human insulin|DRUG: insulin analogue
|
| Outcome Measures: |
Primary: Percentage of patients achieving HbA1c below 7.0%, at 16 weeks | Secondary: HbA1c change from baseline, at 16 weeks|Incidence of major, minor and symptoms only hypoglycaemic episodes, at 16 weeks|Comparison of scores of Insulin Treatment Appraisal Scale (ITAS), at baseline and at 16 weeks
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
4847
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2008-12
|
| Completion Date: |
2009-12
|
| Results First Posted: |
|
| Last Update Posted: |
2016-10-28
|
| Locations: |
Novo Nordisk Investigational Site, Beijing, Beijing, 100004, China
|
| URL: |
https://clinicaltrials.gov/show/NCT00806936
|
